Cipla

Cipla Q3 net profit rises seven per cent to Rs 808 crore

Read more

Cipla and Ethris partner to develop mRNA-based therapies

Read more

Cipla’s higher automation spends to continue for three more years: CTO

Read more

US FDA designates Cipla’s Goa plant as ‘Official Action Indicated’

Read more

Cipla beats estimates with 11 per cent rise in quarterly profit

Read more

Cipla’s Indore plant joins WEF’s Lighthouse Network

Read more

Cipla gets US FDA nod for cancer drug

Read more

Glenmark, Strides Pharma and Cipla recall products in US

Read more

US FDA issues Form 483 to Cipla’s facility in MP

Read more

Cipla betting big on digitisation and emerging segments

Read more